Marc E. Lippman, Director at SEATTLE GENETICS INC /WA (SGEN), sold 52,500 shares at $115.43 ($6.1M) on 2019-11-18, disclosed to the SEC on 2019-11-20.
Open-market sale of $6.1M SGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $115.43 | 17,500 | $2.0M | 33.3% |
| 2 | $115.43 | 17,500 | $2.0M | 33.3% |
| 3 | $116.17 | 17,500 | $2.0M | 33.5% |
| Total | $115.68 avg | 52,500 | $6.1M | 100% |
| Filing → |
| SGEN | SELL | 2018-08-02 | $512K | — | Filing → |
| SGEN | SELL | 2017-11-17 | $174K | — | Filing → |
| SGEN | SELL | 2016-11-09 | $58K | — | Filing → |